RX509 (Amoxicillin and Clavulanate 875 mg / 125mg)
Pill imprint RX509 has been identified as Amoxicillin and clavulanate potassium 875 mg / 125mg.
Amoxicillin/clavulanate is used in the treatment of sinusitis; bacterial infection; urinary tract infection; strep throat; bronchitis (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 875 mg / 125mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RX509 (Amoxicillin and Clavulanate 875 mg / 125mg)
- 875 mg / 125mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Beta-lactamase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|51079-0267||UDL Laboratories Inc|
|68084-0236||Amerisource Health Services|
|57866-3129||Direct Dispensing Inc (repackager)|
|16590-0020||Stat RX USA LLC (repackager)|
|58016-4990||Southwood Pharmaceuticals Inc (repackager)|
|33358-0031||Core Pharmaceuticals Inc (repackager)|
|49999-0177||Lake Erie Medical and Surgical Supply (repackager)|
|43063-0077||PDRX Pharmaceuticals Inc (repackager)|
|55289-0767||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about amoxicillin/clavulanate
- Amoxicillin and Clavulanate
- Amoxicillin/clavulanate chewable tablets
- Amoxicillin/clavulanate extended-release tablets
- Amoxicillin/clavulanate suspension
- More (2) »